SAGNELLI, Evangelista
 Distribuzione geografica
Continente #
EU - Europa 6.768
AS - Asia 3.155
NA - Nord America 2.993
SA - Sud America 574
AF - Africa 52
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 13.547
Nazione #
RU - Federazione Russa 4.711
US - Stati Uniti d'America 2.931
SG - Singapore 1.085
IE - Irlanda 867
HK - Hong Kong 654
CN - Cina 489
BR - Brasile 484
VN - Vietnam 484
IT - Italia 260
GB - Regno Unito 241
UA - Ucraina 198
DE - Germania 193
KR - Corea 154
JP - Giappone 94
GR - Grecia 70
IN - India 63
FI - Finlandia 46
FR - Francia 45
SE - Svezia 42
AR - Argentina 40
CA - Canada 33
TR - Turchia 31
BD - Bangladesh 24
IQ - Iraq 19
ZA - Sudafrica 19
EC - Ecuador 17
BE - Belgio 16
MX - Messico 14
AT - Austria 13
PL - Polonia 13
CO - Colombia 11
EG - Egitto 11
ID - Indonesia 10
PK - Pakistan 10
CZ - Repubblica Ceca 7
NL - Olanda 7
RS - Serbia 7
ES - Italia 6
VE - Venezuela 6
DZ - Algeria 5
PE - Perù 5
PY - Paraguay 5
CH - Svizzera 4
KE - Kenya 4
KG - Kirghizistan 4
UZ - Uzbekistan 4
AL - Albania 3
BG - Bulgaria 3
CL - Cile 3
DO - Repubblica Dominicana 3
EE - Estonia 3
IL - Israele 3
KZ - Kazakistan 3
LT - Lituania 3
MA - Marocco 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
AE - Emirati Arabi Uniti 2
BO - Bolivia 2
BY - Bielorussia 2
CM - Camerun 2
CR - Costa Rica 2
GE - Georgia 2
IR - Iran 2
JM - Giamaica 2
JO - Giordania 2
LB - Libano 2
MY - Malesia 2
PA - Panama 2
PH - Filippine 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
AM - Armenia 1
AU - Australia 1
AZ - Azerbaigian 1
BB - Barbados 1
BH - Bahrain 1
CI - Costa d'Avorio 1
DK - Danimarca 1
EU - Europa 1
GT - Guatemala 1
HN - Honduras 1
HU - Ungheria 1
KN - Saint Kitts e Nevis 1
LV - Lettonia 1
MD - Moldavia 1
MM - Myanmar 1
MZ - Mozambico 1
NP - Nepal 1
NR - Nauru 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
PT - Portogallo 1
SA - Arabia Saudita 1
SC - Seychelles 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TW - Taiwan 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 13.547
Città #
Moscow 1.721
Dublin 867
Hong Kong 648
Santa Clara 497
Singapore 442
Jacksonville 313
San Jose 259
Chandler 227
Ashburn 160
Ho Chi Minh City 155
Seoul 154
Hanoi 125
Princeton 124
Bremen 120
Roxbury 120
Beijing 100
Ann Arbor 96
Medford 69
Caserta 63
Cambridge 59
Dallas 58
The Dalles 56
New York 48
Los Angeles 47
São Paulo 36
Woodbridge 32
Da Nang 31
Wilmington 28
Haiphong 25
Des Moines 24
Washington 23
Houston 22
Munich 22
Memphis 21
Bengaluru 20
Mountain View 20
Nanjing 19
Orem 19
Hefei 18
Chennai 17
Brussels 16
Jinan 16
Napoli 16
Rio de Janeiro 15
Brasília 13
Guangzhou 13
Biên Hòa 12
Manchester 11
Milan 11
Nanchang 11
Ninh Bình 11
Warsaw 11
Boardman 10
Montreal 10
Nuremberg 10
Atlanta 9
Hangzhou 9
Johannesburg 9
Rome 9
Tianjin 9
London 8
Manaus 8
Naples 8
San Francisco 8
Vũng Tàu 8
Ariano Irpino 7
Belgrade 7
Belo Horizonte 7
Curitiba 7
Frankfurt am Main 7
Guayaquil 7
Hải Dương 7
Mumbai 7
Paris 7
Recife 7
Shanghai 7
Tokyo 7
Zhengzhou 7
Brno 6
Cairo 6
Can Tho 6
Changsha 6
Porto Alegre 6
San Mateo 6
Seattle 6
Shenyang 6
São Gonçalo 6
Baghdad 5
Brooklyn 5
Bến Tre 5
Campinas 5
Caxias do Sul 5
Columbus 5
Denver 5
Dhaka 5
Huế 5
João Pessoa 5
Lanzhou 5
Mauá 5
New Delhi 5
Totale 7.386
Nome #
Association Between a Polymorphism in Cannabinoid Receptor 2 and Severe Necroinflammation in Patients With Chronic Hepatitis C. 191
Characteristics of liver cirrhosis in Italy: Evidence for a decreasing role of HCV aetiology. 179
How Fear of COVID-19 Can Affect Treatment Choices for Anaplastic Large Cell Lymphomas ALK+ Therapy: A Case Report 178
Cannabinoid Receptor 2 (CB2) Q63 variant in chronic hepatitis C: an association with a more severe hepatocellular necrosis. 176
Hepatocellular carcinoma in chronic HBV-HCV co-infection is correlated to fibrosis and disease duration 175
Antidepressant-Induced Acute Liver Injury: A Case-Control Study in an Italian Inpatient Population 172
CB2-63 polymorphism and immune-mediated diseases associated with HCV chronic infection. 170
Micro-RNAs in hepatitis B virus-related chronic liver diseases and hepatocellular carcinoma 167
Absence of occult HCV infection in patients experiencing an immunodepression condition 163
Blood-borne chronic viral infections in a large cohort of immigrants in southern Italy: A seven-centre, prospective, screening study 161
Association between anti-HBc positivity and hepatocellular carcinoma in HBsAg-negative subjects with chronic liver disease: A meta-analysis 160
Cannabinoid receptor 2-63 RR variant is independently associated with severe necroinflammation in HIV/HCV coinfected patients. 160
Lowered expression of microRNA-125a-5p in human hepatocellular carcinoma and up-regulation of its oncogenic targets sirtuin-7, matrix metalloproteinase-11, and c-Raf 159
Eighteen-month lamivudine prophylaxis on preventing occult hepatitis B virus infection reactivation in patients with haematological malignancies receiving immunosuppression therapy 158
Correlation between the hepatic expression of human microRNA hsa-miR-125a-5p and the progression of fibrosis in patients with overt and occult HBV infection 155
Hepatitis B virus, hepatitis C virus and human immunodeficiency virus infection in undocumented migrants and refugees in southern Italy, January 2012 to June 2013 151
Clinical findings of HCV chronic infection in undocumented immigrants and low-income refugees in three areas of southern Italy 150
Characteristics of patients with hepatitis C virus-related chronic liver diseases just before the era of oral direct-acting antiviral therapy in Italy. 150
Recommendations for the management of acute hepatitis B: position paper of the italian Society for the study of infectious and tropical diseases 141
Acute hepatitis C: Clinical and laboratory diagnosis, course of the disease, treatment 138
Characteristics and Changes over Time of Alcohol-Related Chronic Liver Diseases in Italy 138
Recommendations for the use of Hepatitis C virus protease inhibitors for the treatment of chronic Hepatitis C in HIV-infected persons. A position paper of the Italian Association for the Study of Infectious and Tropical Disease. 137
Clinical significance of hepatitis B surface antigen mutants 137
Impact of PNPLA3 variants on liver histology of 168 patients with HIV infection and chronic hepatitis C. 137
Hepatitis B virus infection in undocumented immigrants and refugees in Southern Italy: demographic, virological, and clinical features 137
Virological patterns of HCV patients with failure to interferon-free regimens. 136
The long-term immunogenicity of recombinant hepatitis B virus (HBV) vaccine: Contribution of universal HBV vaccination in Italy 133
The TM6SF2 E167K variant in HIV/HCV coinfection predicts severe liver fibrosis and, only for patients with HCV genotype non 3 severe steatosis. 133
Advances in the treatment of hepatitis B virus/hepatitis C virus coinfection 132
Epidemiology and management of hepatitis C virus infections in immigrant populations 130
Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update 2011. 129
Occult HBV infection in HCC and cirrhotic tissue of HBsAg-negative patients: a virological and clinical study. 128
Hepatitis delta infection in Italian patients: towards the end of the story? 126
Epidemiological and etiological variations in hepatocellular carcinoma 125
Absence of occult HCV infection in HIV-positive patients 125
Low prevalence of HTLV1/2 infection in a population of immigrants living in southern Italy 123
Patatin-Like Phospholipase Domain-Containing 3 I148M Variant Is Associated with Liver Steatosis and Fat Distribution in Chronic Hepatitis B 122
Acute hepatitis with severe cholestasis and prolonged clinical course due to hepatitis A virus Ia and Ib coinfection 122
Chronic HBV infection in pregnantimmigrants: a multicenter study of the Italian Society of Infectious and TropicalDiseases. 120
Absence of occult hepatitis C virus infection in patients under immunosupressive therapy for oncohematological diseases 120
The TM6SFZ 8167K variant is an independent predictor of severe liver steatosis in chronic hepatitis C 118
Primary extra-nodal dlbcl of glands: Our experiences outside guidelines of treatment 118
Hepatitis C virus superinfection in hepatitis B virus chronic carriers: A reciprocal viral interaction and a variable clinical course 116
Role of genetic polymorphisms in hepatitis C virus chronic infection 116
PNPLA3 I148M variant is associated with liver steatosis and fat distribution in chronic hepatitis B 115
Clinical and virological characteristics associated with severe acute hepatitis B 115
Multiple Hepatitis B Virus (HBV) Quasispecies and Immune-Escape Mutations Are Present in HBV Surface Antigen and Reverse Transcriptase of Patients With Acute Hepatitis B 113
Treatment of chronic HBV infection in developing countries. 113
An update on the treatment options for HBV/HCV coinfection 111
Clinical Presentation, Outcome, and Response to Therapy Among Patients With Acute Exacerbation of Chronic Hepatitis C 110
Tolerability and efficacy of anti-HBV nucleos(t)ide analogues in HBV-DNA-positive cirrhotic patients with HBV/HCV dual infection 110
Chronic hepatitis B in Italy: new features of an old disease--approaching the universal prevalence of hepatitis B e antigen-negative cases and the eradication of hepatitis D infection. 109
The CB2-63 RR variant is an independent predictor of severe liver necroinflammation in chronic hepatitis B 109
The association between education level and chronic liver disease of any etiology 108
Improvement in the aetiological diagnosis of acute hepatitis C: A diagnostic protocol based on the anti-HCV-IgM titre and IgG Avidity Index 108
Reactivation of overt and occult hepatitis B infection in various immunosuppressive settings 106
Role of occult hepatitis B virus infection in chronic hepatitis C 106
Effect of a Cooperation Strategy between Primary Care Physicians and Hospital Liver Units on HBV Care in Campania, Italy 105
Hepatitis C late relapse in patients with directly acting antiviral-related sustained virological response at week 12 105
Patients with HCV genotype-1 who have failed a direct-acting antiviral regimen: virological characteristics and efficacy of retreatment 104
Liver fibrosis in human immunodeficiency virus/hepatitis C virus coinfection: Diagnostic methods and clinical impact 104
HDV infection in immigrant populations 103
Italian consensus Guidelines for the management of hepatitis B virus infections in patients with rheumatoid arthritis 102
HBV molecular epidemiology and clinical condition of immigrants living in Italy 102
Influence of universal HBV vaccination on chronic HBV infection in Italy: Results of a cross-sectional multicenter study 101
Role of occult hepatitis B virus infection in chronic hepatitis C 100
Role of ITPA and IL28B variants in the management of chronic hepatitis C treatment 100
Liver fibrosis in human immunodeficiency virus/hepatitis C virus coinfection: Diagnostic methods and clinical impact 100
Hbv/hdv co‐infection: Epidemiological and clinical changes, recent knowledge and future challenges 100
Clinical impact of occult hepatitis B virus infection in immunosuppressed patients 100
What is changed in HBV molecular epidemiology in Italy? 98
In vivo evidence that the cannabinoid receptor 2-63 RR variant is associated with the acquisition and/or expansion of HIV infection 98
Post Heart Transplantation Lymphoproliferative Diseases (PLDs) and the diagnostic role of [18f] FDG- PET/CT 98
Reactivation of hepatitis B virus infection in patients with hemo-lymphoproliferative diseases, and its prevention 96
The burden of HBV infection in HCV patients in Italy and the risk of reactivation under DAA therapy 95
Molecular epidemiology of HIV-1 infection in immigrant population in northern Italy 95
Genotype I hepatitis A virus introduction in Italy: Bayesian phylogenetic analysis to date different epidemics 94
Decreasing role of HCV and HBV infections as aetiological factors of hepatocellular carcinoma in Italy 94
Role of genetic polymorphisms in hepatitis C virus chronic infection 94
Epidemiological and clinical scenario of chronic liver diseases in Italy: Data from a multicenter nationwide survey 91
Impact of DAA-Based Regimens on HCV-Related Extra-Hepatic Damage: A Narrative Review 90
TM6SF2 E167K variant predicts severe liver fibrosis for human immunodeficiency/hepatitis C virus co-infected patients, and severe steatosis only for a non-3 hepatitis C virus genotype 89
Hepatitis c virus markers in infection by hepatitis c virus:In the era of directly acting antivirals 89
Etiological factors of chronic hepatitis in Italy: a 2014 national survey 89
Interferon-Free Regimens in HBsAg/anti-HCV Patients: The Need to Control HBV Replication to Avoid HBV Reactivation. 89
Gender differences in chronic liver diseases in two cohorts of 2001 and 2014 in Italy 89
Migratory flow and hepatitis delta infection in Italy: A new challenge at the beginning of the third millennium 89
Sex difference in the interaction of alcohol intake, hepatitis B virus, and hepatitis C virus on the risk of cirrhosis 88
Gender differences in chronic HBsAg carriers in Italy: Evidence for the independent role of male sex in severity of liver disease 88
Hepatitis C virus infection and prisoners: Epidemiology, outcome and treatment 88
Hepatitis B virus burden in developing countries 87
Hepatitis A virus strains circulating during 1997-2015 in Campania, a SouthernItaly region with periodic outbreaks. 87
Human hepatitis E virus circulation in Bulgaria: deep Bayesian phylogenetic analysis for viral spread control in the country 87
The phylogenetic approach for viral infectious disease evolution and epidemiology: An updating review 87
Interferon-Free Regimens in Hepatitis B Surface Antigen/Anti-Hepatitis C Virus Positive Patients: The Need to Control Hepatitis B Virus Replication to Avoid Hepatitis B Virus Reactivation. 86
Therapeutic strategies for severe COVID-19: a position paper from the Italian Society of Infectious and Tropical Diseases (SIMIT) 86
Hepatitis B virus, hepatitis C virus and human immunodeficiency virus infection in undocumented migrants and refugees in southern Italy, january 2012 to june 2013 85
Clinical impact of the hepatitis C virus mutations in the era of directly acting antivirals. 84
Hepatitis B virus infection in immigrant populations 83
Geographical pattern of chronic liver diseases in Italy: Results from two pooled national surveys 83
Totale 11.767
Categoria #
all - tutte 49.983
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.983


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20216 0 0 0 0 0 0 0 0 0 0 0 6
2021/2022681 7 4 1 5 198 5 55 13 21 82 33 257
2022/20231.317 132 32 19 53 186 60 0 56 742 7 17 13
2023/2024538 36 14 37 21 211 43 2 22 2 8 25 117
2024/20252.023 4 14 13 33 276 286 280 158 289 431 148 91
2025/20267.791 303 324 378 447 633 4.377 500 248 264 147 102 68
Totale 13.858